Clinical Trial Update: Rectal Indomethacin and Oral Tacrolimus Versus Combination to Prevent Post-ERCP Pancreatitis [Phase 3]

View source ↗

Summary

Phase 3 randomized trial evaluating whether rectal indomethacin and oral tacrolimus are more effective than either approach alone in preventing post-ERCP pancre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-ercp Acute Pancreatitis

Drugs mentioned

• INDOMETHACIN (INDOMETHACIN)
• Tacrolimus (Tacrolimus)

Snippet

Sponsor: Johns Hopkins University | Conditions: Post-ERCP Acute Pancreatitis | Phase 3 | Status: RECRUITING